Kazazian Asset Management LLC Purchases Shares of 121,800 SelectQuote, Inc. (NYSE:SLQT)

Kazazian Asset Management LLC bought a new position in SelectQuote, Inc. (NYSE:SLQT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 121,800 shares of the company's stock, valued at approximately $453,000. Kazazian Asset Management LLC owned 0.07% of SelectQuote at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Geode Capital Management LLC lifted its stake in shares of SelectQuote by 1.4% in the third quarter. Geode Capital Management LLC now owns 3,081,391 shares of the company's stock worth $6,688,000 after acquiring an additional 43,197 shares in the last quarter. State Street Corp lifted its stake in shares of SelectQuote by 0.7% in the third quarter. State Street Corp now owns 2,894,067 shares of the company's stock worth $6,280,000 after acquiring an additional 21,413 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of SelectQuote by 0.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,191,701 shares of the company's stock worth $4,433,000 after acquiring an additional 10,038 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its stake in SelectQuote by 23.9% during the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 772,831 shares of the company's stock valued at $2,875,000 after buying an additional 149,283 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in SelectQuote by 36.9% during the third quarter. JPMorgan Chase & Co. now owns 429,656 shares of the company's stock valued at $932,000 after buying an additional 115,865 shares in the last quarter. Hedge funds and other institutional investors own 34.59% of the company's stock.

Remove Ads

Insider Transactions at SelectQuote

In related news, insider Sarah Taylor Anderson sold 50,000 shares of the stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $5.44, for a total value of $272,000.00. Following the completion of the transaction, the insider now directly owns 1,166 shares of the company's stock, valued at $6,343.04. This represents a 97.72 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 11.40% of the company's stock.

Wall Street Analyst Weigh In

Separately, Noble Financial upgraded SelectQuote to a "strong-buy" rating in a research note on Wednesday, February 12th.

SelectQuote Stock Down 0.7 %

NYSE SLQT traded down $0.03 on Friday, hitting $3.79. 1,396,119 shares of the stock traded hands, compared to its average volume of 1,283,442. The company has a current ratio of 6.36, a quick ratio of 6.36 and a debt-to-equity ratio of 2.10. The stock has a 50-day moving average of $4.37 and a 200 day moving average of $3.28. The company has a market capitalization of $651.57 million, a P/E ratio of -42.06 and a beta of 1.13. SelectQuote, Inc. has a twelve month low of $1.48 and a twelve month high of $6.86.

SelectQuote (NYSE:SLQT - Get Free Report) last announced its quarterly earnings results on Monday, February 10th. The company reported $0.30 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.21. SelectQuote had a negative return on equity of 4.38% and a negative net margin of 0.95%. As a group, analysts expect that SelectQuote, Inc. will post -0.07 earnings per share for the current fiscal year.

About SelectQuote

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.